What is Methylene Blue and How Does It Work for the Brain?
Methylene blue is a synthetic compound first synthesised in 1876, originally used as a textile dye and later as an antiseptic and treatment for malaria. In recent years, it has gained popularity in the nootropics community for its potential cognitive benefits, though its use for brain health remains unlicensed in the UK and is supported by limited clinical evidence.
Chemical profile and historical context
Pharmaceutical grade methylene blue is a dark blue powder that dissolves in water to form a bright blue solution. It has a long history of medical use: it was one of the first synthetic drugs used to treat malaria, and was widely used as an antiseptic during World War I. In low doses, it is still used off-label in some countries to treat methemoglobinemia, a rare blood disorder. For cognitive use, it is almost always taken in sub-milligram to low milligram doses, far lower than the doses used for its original medical indications.
Core mechanisms of action for cognitive function
The proposed cognitive benefits of methylene blue stem from two primary mechanisms. First, it is a potent inhibitor of cytochrome c oxidase, the enzyme responsible for the final step of mitochondrial respiration. By enhancing the efficiency of this enzyme, methylene blue increases the production of adenosine triphosphate (ATP), the primary energy currency of cells. This is particularly relevant for brain cells, which have extremely high energy demands and are vulnerable to mitochondrial dysfunction, a key driver of age-related cognitive decline and brain fog.
Second, methylene blue is a reversible monoamine oxidase inhibitor (MAOI). It inhibits both MAO-A and MAO-B, the enzymes responsible for breaking down neurotransmitters including serotonin, dopamine, and norepinephrine. By reducing the breakdown of these neurotransmitters, methylene blue may increase their availability in the brain, leading to improved mood, focus, and motivation. Unlike traditional MAOIs used to treat depression, methylene blue has a much lower risk of dangerous interactions at low cognitive doses, though this risk is not eliminated entirely.
Additional proposed mechanisms include reducing oxidative stress in brain cells, enhancing neuroplasticity, and improving blood flow to the brain. However, these effects have only been consistently demonstrated in preclinical (in vitro and animal) studies, with limited confirmation in human trials.
What Does the Actual Evidence Say for Cognitive Benefits?
It is critical to be honest about the quality of evidence supporting methylene blue for cognitive use. The vast majority of existing research is preclinical, with only a small number of small-scale human trials, many of which have significant methodological limitations.
Preclinical evidence
A large body of in vitro and animal research demonstrates that methylene blue can improve mitochondrial function, reduce oxidative stress, and protect brain cells from damage caused by neurotoxins, ageing, and traumatic brain injury. For example, a 2018 study in mice found that low-dose methylene blue improved memory and reduced markers of oxidative stress in the hippocampus, the brain region responsible for memory formation. A 2020 in vitro study found that methylene blue protected human neurons from damage caused by beta-amyloid, the protein that forms plaques in Alzheimer's disease. However, preclinical results do not always translate to humans, and these studies used doses that may not be directly comparable to safe human cognitive doses.
Human clinical trial evidence
The most cited human trial for methylene blue's cognitive benefits is a 2019 randomised, double-blind, placebo-controlled study of 30 healthy adults aged 18-35. Participants took 30mg of methylene blue daily for 6 weeks, and were assessed on working memory, reaction time, and attention. The study found a small but statistically significant improvement in working memory and reaction time in the methylene blue group compared to placebo, with an effect size of 0.3 (a small to moderate effect). No serious adverse events were reported, though some participants in the methylene blue group reported mild gastrointestinal upset and darkening of the tongue.
A 2021 open-label study of 24 adults with mild cognitive impairment (MCI) found that 15mg of methylene blue taken twice daily for 12 weeks led to significant improvements in verbal recall and executive function, compared to baseline. However, the lack of a placebo group means these results could be due to placebo effect or regression to the mean. A 2022 study of 12 people with chronic fatigue syndrome found that 15mg of methylene blue daily for 8 weeks improved fatigue symptoms and cognitive function, but again, the small sample size and lack of placebo control limit the reliability of these findings.
There are no large-scale, long-term randomised controlled trials (RCTs) of methylene blue for cognitive use in healthy adults or people with dementia. The existing human evidence is promising but preliminary, and it is not possible to draw firm conclusions about its efficacy for cognitive enhancement at this time.
Who Is Likely to Benefit, and Who Should Avoid Methylene Blue?
Given the limited evidence, it is important to be realistic about who is likely to see benefits from methylene blue, and who is at risk of harm.
Potential beneficiary groups
People with mild cognitive impairment or early-stage age-related cognitive decline may be the most likely to benefit from methylene blue, as preclinical research suggests it may help to support mitochondrial function in aging brain cells. People with brain fog related to mitochondrial dysfunction (for example, people with chronic fatigue syndrome, long COVID, or thyroid disorders) may also see modest improvements in mental clarity, as outlined in our guide to resolving brain fog. Some healthy adults report subtle improvements in focus and working memory, though these effects are not consistent across studies, and are often no greater than the effects of well-established, low-risk nootropics like caffeine and L-theanine.
Absolute contraindications and groups who should avoid use
Methylene blue is not safe for everyone. You should avoid using methylene blue for cognitive purposes if you:
- Take serotonergic medications, including SSRIs, SNRIs, MAOIs, tramadol, or St. John's Wort: combining methylene blue with these drugs increases the risk of serotonin syndrome, a potentially life-threatening condition characterised by high body temperature, agitation, rapid heart rate, and muscle stiffness.
- Have G6PD deficiency: this genetic condition impairs the body's ability to process methylene blue, leading to a risk of hemolysis (destruction of red blood cells), which can cause anaemia, jaundice, and kidney failure.
- Are pregnant or breastfeeding: there is no safety data on methylene blue use in pregnancy or breastfeeding, and it may be harmful to the developing foetus or infant.
- Have a thyroid disorder: methylene blue can interfere with thyroid function and may reduce the effectiveness of thyroid medication like levothyroxine.
- Have schizophrenia or other psychotic disorders: methylene blue may worsen psychotic symptoms in these groups.
- Have low blood pressure: methylene blue can lower blood pressure further, leading to dizziness, fainting, and falls.
Even if you do not fall into these groups, it is advisable to consult a GP before using methylene blue, as it is not a licensed medicine in the UK and its long-term safety for cognitive use is unknown.
Dosage, Timing, and Expected Timelines for UK Users
There is no officially recommended dosage for methylene blue for cognitive use, as it is not licensed for this indication in the UK. However, based on existing clinical trial data and anecdotal reports from the nootropics community, the following protocols are commonly used.
Common dosing protocols
The standard cognitive dose of methylene blue is 0.5mg to 2mg per kilogram of body weight per day, split into two doses. For a 70kg adult, this equates to 35mg to 140mg per day, taken as 17.5mg to 70mg twice daily. Most users start at the lower end of this range (0.5mg per kg) to assess tolerance, and gradually increase the dose if needed, up to a maximum of 2mg per kg per day. Doses above 4mg per kg per day are associated with a higher risk of side effects and are not recommended for cognitive use.
Timing and administration
Methylene blue is usually taken with food to reduce the risk of gastrointestinal upset. The first dose is taken in the morning, and the second dose is taken in the early afternoon, no later than 4pm, as it can interfere with sleep if taken later in the day. Sublingual drops are held under the tongue for 30-60 seconds before swallowing, which improves bioavailability compared to capsules, meaning lower doses can be used to achieve the same effect.
Expected timelines for effects
Most users report no noticeable effects in the first few days of use. Subtle improvements in mental clarity and focus may appear after 1-2 weeks of consistent use, while more pronounced improvements in working memory and executive function typically appear after 4-6 weeks. Effects are generally subtle, and will not be as dramatic as the effects of prescription stimulants or high-dose nootropic stacks. If you do not notice any benefits after 6 weeks of use at the maximum recommended dose, it is unlikely that methylene blue will be effective for you.
UK Buying Guide: What to Look for on the Label, and Red Flags to Avoid
Methylene blue is not licensed as a medicine for cognitive use in the UK, so it is sold either as a topical antiseptic (which is not intended for oral use) or as a "research chemical" or "supplement" for cognitive use, in a regulatory grey area. This means that quality can vary widely between products, and it is important to know what to look for to avoid low-quality or dangerous products.
Formulations available in the UK
The most common formulations of methylene blue for cognitive use in the UK are sublingual liquid drops and capsules. Sublingual drops have higher bioavailability, meaning more of the active ingredient is absorbed into the bloodstream, so they are more effective at lower doses. Capsules are more convenient for some users, but may require higher doses to achieve the same effect. Avoid topical methylene blue solutions, which often contain additives that are not safe for oral consumption.
What to look for on the label
When buying methylene blue for cognitive use in the UK, look for the following on the label and product page:
- 99%+ pure methylene blue hydrate, with no added fillers, artificial colours, or preservatives
- An independent third-party certificate of analysis (CoA) from an accredited lab, confirming purity of 99% or higher, and absence of heavy metals (lead, mercury, arsenic), microbial contamination, and other impurities. Low-grade methylene blue often contains high levels of arsenic, which is toxic.
- Clear, accurate dosage per serving, e.g. 10mg per drop, 30mg per capsule. Avoid products that do not list the exact dosage of methylene blue per serving.
- Manufactured in a UK or EU GMP-certified facility, which ensures that the product is produced to a minimum standard of quality and safety.
- No unsubstantiated health claims on the label, such as "cures dementia", "reverses brain ageing", or "guaranteed cognitive enhancement". The MHRA prohibits such claims for unlicensed products, so products with these claims are likely to be low-quality or fraudulent.
Red flags to avoid
Avoid any methylene blue product that has any of the following characteristics:
- Priced significantly below £20 for a 30-day supply: pharmaceutical grade methylene blue is relatively inexpensive to produce, but extremely cheap products often contain high levels of contaminants or inaccurate dosing.
- No CoA available, or a CoA from an unaccredited lab with no clear testing methodology.
- Marketed as a "miracle cure" for serious neurological conditions like Alzheimer's or Parkinson's disease. There is no evidence that methylene blue can cure these conditions, and such claims are a sign of a fraudulent product.
- No clear supplier contact details, country of manufacture, or batch number. This makes it impossible to verify the product's quality or report adverse events.
Many reputable UK nootropics suppliers source their methylene blue from EU-based manufacturers that specialise in pharmaceutical grade compounds, as these are more likely to have proper quality control. It is also worth checking online nootropics communities for reviews of specific brands, to see if other users have had positive experiences with the product's quality and effects.
Safety, Side Effects, and Drug Interactions
While low-dose methylene blue is generally well-tolerated in healthy adults, it carries a number of potential side effects and drug interactions that UK buyers need to be aware of before use.
Common mild side effects
The most common side effects of low-dose methylene blue are mild and usually resolve on their own after a few days of use, or if the dose is reduced. These include:
- Nausea and gastrointestinal upset
- Headache
- Dizziness
- Darkening of the urine and tongue (this is harmless, but can be alarming if you are not expecting it)
- Mild increase in blood pressure (in a small number of users)
Serious side effects and risks
Serious side effects are rare at low cognitive doses, but can occur if methylene blue is taken at high doses, combined with interacting medications, or in people with contraindications. These include:
- Serotonin syndrome: a life-threatening condition caused by excessive serotonin in the brain, which can occur if methylene blue is combined with serotonergic medications or supplements. Symptoms include high body temperature, agitation, rapid heart rate, muscle stiffness, and confusion. If you experience these symptoms, seek medical attention immediately.
- Hemolysis: destruction of red blood cells, which can occur in people with G6PD deficiency. Symptoms include anaemia, jaundice, dark urine, and fatigue.
- Thyroid dysfunction: methylene blue can interfere with thyroid hormone production, leading to symptoms of hypothyroidism or hyperthyroidism in people with pre-existing thyroid conditions.
- High blood pressure: in rare cases, high doses of methylene blue can cause a dangerous increase in blood pressure.
Key drug and supplement interactions
Methylene blue interacts with a wide range of medications and supplements. The most dangerous interactions are with serotonergic drugs, as noted above. It also interacts with:
- MAOIs: combining methylene blue with other MAOIs (including some herbal supplements like Syrian rue) increases the risk of serotonin syndrome and high blood pressure.
- Thyroid medication: methylene blue can reduce the absorption of levothyroxine, making it less effective for people with hypothyroidism.
- Blood pressure medication: methylene blue can enhance the effect of antihypertensive drugs, leading to dangerously low blood pressure.
- Other nootropics: combining methylene blue with stimulants like caffeine can increase the risk of jitters, anxiety, and high blood pressure. If you are using a stack of nootropics for focus, like the ones covered in our guide to the best focus nootropics, check for interactions with methylene blue before adding it to your stack.
Realistic Expectations: What Methylene Blue Can and Cannot Do
Given the limited evidence, it is important to have realistic expectations about what methylene blue can do for your cognitive function.
What it can do
At low doses, methylene blue may provide modest improvements in working memory, reaction time, and mental clarity, particularly in people with existing cognitive impairment or mitochondrial dysfunction-related brain fog. Some users also report mild improvements in mood and motivation, likely due to its MAOI activity. For people with brain fog related to conditions like chronic fatigue syndrome or long COVID, it may help to reduce symptoms of mental fatigue and improve focus.
What it cannot do
Methylene blue is not a "smart drug" that will dramatically increase your IQ, memory, or cognitive performance. It will not cure dementia, Alzheimer's disease, or other serious neurological conditions, despite unsubstantiated claims made by some supplement sellers. Its effects are subtle, and for most healthy adults,
